CAZypedia needs your help! We have many unassigned GH, PL, CE, AA, GT, and CBM pages in need of Authors and Responsible Curators.
Scientists at all career stages, including students, are welcome to contribute to CAZypedia. Read more here, and in the 10th anniversary article in Glycobiology.
New to the CAZy classification? Read this first.
*
Consider attending the 15th Carbohydrate Bioengineering Meeting in Ghent, 5-8 May 2024.

Glycoside Hydrolase Family 53

From CAZypedia
Jump to navigation Jump to search
Under construction icon-blue-48px.png

This page is currently under construction. This means that the Responsible Curator has deemed that the page's content is not quite up to CAZypedia's standards for full public consumption. All information should be considered to be under revision and may be subject to major changes.


Glycoside Hydrolase Family GH53
Clan GH-A
Mechanism retaining
Active site residues known
CAZy DB link
http://www.cazy.org/fam/GH53.html


Substrate specificities

The only known specificity for this family is beta-1,4-galactanase (EC 3.2.1.89) and the only reported function is the microbial degradation of galactans and arabinogalactans in the pectic component of plant cell walls. A number of patents on industrial applications of GH53 have been filed.

Kinetics and Mechanism

GH53 beta-1,4-galactanases follow a classical retaining mechanism as first demonstrated by following the stereochemical course of rection for the endo-beta-1,4-galactanase of the bacterium Cellvibrio japonicus (at that time referred to as Pseudomonas fluorescens subspecies cellulosa) [1]. Most characterized members have been reported to have an endo-mode of action, although processivity has been suggested in one case [2].

Catalytic Residues

The catalytic residues were first identified for the endo-beta-1,4-galactanase of the bacterium Cellvibrio japonicus [1] (at that time referred to as Pseudomonas fluorescens subspecies cellulosa). As expected for a member for clan GH-A, the two catalytic residues were, by a combination of mutagenesis and kinetic analysis, identified to be two glutamates, one acting as an acid-base (E161) and the other as a nucleophile (E270).

Three-dimensional structures

As for all members of Clan GH-A (ref), GH53 displays a (beta/alpha)8 barrel structure for the catalytic domain, usually with fairly compact loop structure (ref) and a size range... A disulphide bridging two loops in 3 known fungal structures, is replaced functionally by a calcium ion in one bacterial structure (refs). In most cases the catalytic domain is found in isolation, and not accompanied by accessory domains, but some exceptions exist (refs). For one bacterial member of the family ligand complexes with products have been obtained crystallographically, occupying subsites -4 to -2 and +1 to +2 (refs). Based on these crystal structures, binding of a galactononaose fragment has also been computationally modelled (ref).

Family Firsts

First sterochemistry determination
Cite some reference here, with a short (1-2 sentence) explanation [1].
First catalytic nucleophile identification
Cite some reference here, with a short (1-2 sentence) explanation [2].
First general acid/base residue identification
Cite some reference here, with a short (1-2 sentence) explanation [3].
First 3-D structure
Cite some reference here, with a short (1-2 sentence) explanation [4].

References

  1. Braithwaite KL, Barna T, Spurway TD, Charnock SJ, Black GW, Hughes N, Lakey JH, Virden R, Hazlewood GP, Henrissat B, and Gilbert HJ. (1997). Evidence that galactanase A from Pseudomonas fluorescens subspecies cellulosa is a retaining family 53 glycosyl hydrolase in which E161 and E270 are the catalytic residues. Biochemistry. 1997;36(49):15489-500. DOI:10.1021/bi9712394 | PubMed ID:9398278 [Braithwaite1997]
  2. Hinz SW, Pastink MI, van den Broek LA, Vincken JP, and Voragen AG. (2005). Bifidobacterium longum endogalactanase liberates galactotriose from type I galactans. Appl Environ Microbiol. 2005;71(9):5501-10. DOI:10.1128/AEM.71.9.5501-5510.2005 | PubMed ID:16151143 [Hinz2005]

All Medline abstracts: PubMed